European Journal of Cardiovascular Medicine

Background: Metabolic syndrome (MetS) including dysglycemia, obesity (especially central obesity), high blood pressure, low high-density lipoprotein cholesterol (HDL-C), and elevated triglyceride levels, is a complex of risk factors for type 2 diabetes and cardiovascular disease (CVD). MetS is a disease associated with multiple factors, and the main diagnostic indicators (components) include blood pressure, overweight and obesity, HDL-C, and fasting blood glucose. However, controversy exists about the impact of MetS on the prognosis of patients with CVD. Materials and methods: This are a prospective, cross sectional and observational study was conducted in the Shadan Institute of Medical Sciences Teaching Hospital and Research Center from June 2019 to November 2019 involving 470 students. The study was conducted using the criteria for metabolic syndrome defined by international diabetes federation. Data for height, weight, body mass index, waist circumference, fasting blood glucose, serum cholesterol, serum triglycerides (TG), high density lipoprotein (HDL), and low density lipoprotein were collected